Hironic Co. Ltd - Asset Resilience Ratio
Hironic Co. Ltd (149980) has an Asset Resilience Ratio of 17.42% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2024)
This chart shows how Hironic Co. Ltd's Asset Resilience Ratio has changed over time. Check Hironic Co. Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Hironic Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Hironic Co. Ltd (149980) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩13.94 Billion | 17.42% |
| Total Liquid Assets | ₩13.94 Billion | 17.42% |
Asset Resilience Insights
- Good Liquidity Position: Hironic Co. Ltd maintains a healthy 17.42% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Hironic Co. Ltd Industry Peers by Asset Resilience Ratio
Compare Hironic Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medtronic PLC
XETRA:2M6 |
Medical Devices | 7.91% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Aroa Biosurgery Ltd
AU:ARX |
Medical Devices | 12.13% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
MICROPORT CARDIO.MEDTECH.
F:72X |
Medical Devices | 37.03% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
Annual Asset Resilience Ratio for Hironic Co. Ltd (2014–2024)
The table below shows the annual Asset Resilience Ratio data for Hironic Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 17.42% | ₩13.94 Billion ≈ $9.45 Million |
₩80.01 Billion ≈ $54.22 Million |
-1.27pp |
| 2023-12-31 | 18.69% | ₩14.78 Billion ≈ $10.02 Million |
₩79.10 Billion ≈ $53.60 Million |
-17.47pp |
| 2022-12-31 | 36.16% | ₩24.41 Billion ≈ $16.54 Million |
₩67.51 Billion ≈ $45.75 Million |
+3.61pp |
| 2021-12-31 | 32.54% | ₩20.72 Billion ≈ $14.04 Million |
₩63.67 Billion ≈ $43.15 Million |
-8.39pp |
| 2020-12-31 | 40.93% | ₩18.32 Billion ≈ $12.42 Million |
₩44.76 Billion ≈ $30.33 Million |
+6.53pp |
| 2019-12-31 | 34.41% | ₩16.12 Billion ≈ $10.93 Million |
₩46.87 Billion ≈ $31.76 Million |
+10.80pp |
| 2018-12-31 | 23.61% | ₩10.15 Billion ≈ $6.88 Million |
₩43.01 Billion ≈ $29.15 Million |
-18.72pp |
| 2017-12-31 | 42.32% | ₩21.17 Billion ≈ $14.35 Million |
₩50.03 Billion ≈ $33.91 Million |
-7.34pp |
| 2016-12-31 | 49.67% | ₩22.21 Billion ≈ $15.05 Million |
₩44.72 Billion ≈ $30.31 Million |
-1.80pp |
| 2015-12-31 | 51.46% | ₩23.60 Billion ≈ $15.99 Million |
₩45.86 Billion ≈ $31.08 Million |
-16.80pp |
| 2014-12-31 | 68.26% | ₩36.45 Billion ≈ $24.70 Million |
₩53.40 Billion ≈ $36.19 Million |
-- |
About Hironic Co. Ltd
Hironic Co., Ltd. engages in the manufacture and sale of medical and surgical equipment, and other orthopedic appliances in South Korea and internationally. It offers its products for the MFU and RF, laser, plasma, and cryotherapy. The company was founded in 2007 and is headquartered in Yongin-Si, South Korea.